Trials / Completed
CompletedNCT03848793
A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
A Phase 2, Multiple Centers, Double-blind, Placebo-Controlled, Randomised Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy and safety of Noiiglutide Injection as mono-therapy with different doses in subjects with type 2 diabetes compared to placebo for 16 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HS-20004 | treatment |
Timeline
- Start date
- 2019-03-06
- Primary completion
- 2020-06-04
- Completion
- 2020-12-14
- First posted
- 2019-02-21
- Last updated
- 2022-11-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03848793. Inclusion in this directory is not an endorsement.